Annual Grants
Funding Amount
Up to $500,000 for translational/correlative grants; Up to $800,000 for clinical trials
Deadline
Expected ~November
Based on past cycles
Grant Type
Foundation
Deadline history & next window
- Cycle
- Annual
- Current deadline
- November 15, 2026
- Tracked since
- April 2026
Deadlines typically fall in: November
From the program guidelines: “LOI deadline: Mid-November each year”
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Other requirements
- Researchers with osteosarcoma research proposals
- Studies focused on developing better treatments and ultimately a cure for osteosarcoma
- Both preclinical and clinical research welcome
Overview
Annual Grants Program
Geographic Scope: National and international
Focus Areas:
- Clinical trials of new potential therapies
- Correlative science (evaluation of how and why potential new therapies work or don't work in clinical trials)
- Basic biology of osteosarcoma cancer and its metastasis
- Translational research (pre-clinical research bridging laboratory findings to clinical application)
- High-risk/high-impact research (bold, pioneering ideas that challenge traditional approaches)
Award Amounts:
- Translational/correlative grants: Up to $500,000
- Clinical trials: Up to $800,000
- High-risk/high-impact studies: Variable (e.g., $100,000)
Eligibility:
- Researchers with osteosarcoma research proposals
- Studies focused on developing better treatments and ultimately a cure for osteosarcoma
- Both preclinical and clinical research welcome
Application Process:
- Two-stage annual grant cycle
- Letters of Intent (LOI) due mid-November each year
- Full applications follow LOI acceptance
- Expert review committee evaluates submissions
- Awards announced in spring
What They Fund:
- Research using new technologies
- Projects with clear timeline to clinical testing
- Immunotherapy approaches
- CAR-T cell therapy developments
- Studies on osteosarcoma metastasis prevention
- Genomics and molecular biology research
What They Don't Fund:
- Not explicitly stated
Background:
- OSI launched in 2017 and has awarded over $5 million to osteosarcoma research since inception
- Standard treatments for osteosarcoma have not changed in 40 years
- OSI is a leading funder of osteosarcoma research
- Strategic Advisory Board includes Nobel Prize recipient and experts across multiple disciplines
- Starting in 2019, OSI awards grants in three main categories; added high-risk/high-impact category in 2023
Contact Information:
- Address: 3963 Maple Avenue Suite 390, Dallas, TX 75219
- Phone: 972.903.8408
- Email: info@osinst.org
- Website: osinst.org
How to Apply
Application Process
Two-Stage Annual Grant Cycle:
- Stage One: Letter of Intent (LOI)
- LOI deadline: Mid-November each year
- LOI submissions outline the proposed research
- Stage Two: Full Application
- Invited after LOI acceptance
- Full applications required for selected LOI submissions
Expert Review:
- Submissions evaluated by OSI's expert review committee
- Committee provides feedback to applicants, even those not selected
- Feedback includes specific advice and direction for improvement
Award Announcements:
- Grants announced in spring (typically June)
Post-Award Requirements:
- Principal Investigators must provide progress reports every six months
- Reports shared with OSI Strategic Advisory Board
- Results made available to the public upon completion
- Emphasis on transparency and accountability
Additional Support:
- OSI offers invaluable feedback, advice, and guidance to researchers
- $20,000 spot/ad hoc grants available to help researchers elevate work for future resubmission
- Researchers receive mentorship from Nobel Prize recipient and expert board members
What The Osteosarcoma Institute actually gave
Source: IRS Form 990, 2024
- Grants in 2024
- 8
- Total given
- $1.19M
- Median grant
- $125K
- Range
- $101K–$307K
- By dollars: Massachusetts 26%, California 24%, Georgia 10%. Top recipient cities: Boston, MA; San Francisco, CA; Atlanta, GA.
- 0% of grants with a stated purpose were for general or operating support.
Example grants
Dana Farber Cancer Institute · Boston, MA
Clinical trial and correlative research grants
$307K
University of CA San Francisco · San Francisco, CA
Translational research grants
$175K
Regents of Emory University · Atlanta, GA
Translational research grants
$125K
Regents of Northwestern University · Evanson, IL
Translational research grants
$125K
Baylor College of Medicine · Houston, TX
Translational research grants
$125K
Focus Areas & Funding Uses
Fields of Work
- Science research
- Cancer
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Off-Cycle Grants
The Osteosarcoma Institute
Amount
$20,000 spot or ad hoc grants
Deadline
Rolling (quarterly review)
Partnering for Progress Program (Family and Foundation Co-Funding)
The Osteosarcoma Institute
Amount
Variable based on donor contribution
Deadline
Deadline not published
Discretionary Grants
The Osteosarcoma Institute
Amount
Varies
Deadline
Deadline not published
CLL Global Research Foundation Research Grant
CLL Global Research Foundation
Amount
Up to $150K
Deadline
Deadline not published
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Up to $350,000
Deadline
November 6, 2026
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$50,000 - $300,000
Deadline
November 10, 2026
Ready to apply for Annual Grants?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Annual Grants. Now let's win it.